GL1X · GenesisL1 explorer

Research workbench

ABL1 kinase (T334I_D382N) in complex with asciminib and nilotinib

Analyse ABL1 kinase (T334I_D382N) in complex with asciminib and nilotinib in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5MO4
Type
protein
Length
429 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase ABL1
EC
2.7.10.2
UniProt
P00519
Ligands
NIL, AY7
Pockets
6 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 33% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase ABL1 (EC 2.7.10.2)protein42933% helix, 22% strandP00519

Ligands and binding sites

  • NIL · Nilotinib · ligand · chains A
  • AY7 · asciminib · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18560.750.7967empty
22510.730.8736NIL
31240.610.8523AY7
4820.500.8319empty
5600.360.7915empty

Compared structures

  • 5MO4 · ABL1 kinase (T334I_D382N) in complex with asciminib and nilotinib · the same entry in another collection · chain A against A, TM-score 1.00
  • P00519 · AlphaFold monomer V2.0 prediction for tyrosine-protein kinase ABL1 (P00519) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.